ArticleDrugs in R&D2017

A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis.

Koichiro Homma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.